Skip to main content

Diabetic Neuropathic Ulcers: Recognizing the Significant Burden and Renewing a Treatment Option

Click HERE to view.

Summary/Objectives of Presentation:

  • Establish prevalence and impact of lower extremity diabetic neuropathic ulcers
  • Review the components of good ulcer care
  • Present the first and only FDA-approved PDGF therapy for the treatment of lower extremity diabetic neuropathic ulcers


Jeffrey D. Lehrman, DPM, FASPS, MAPWCA, CPC
Dr. Lehrman, recently named one of America’s Most Influential Podiatrists, is in private practice in Fort Collins, CO and operates Lehrman Consulting, LLC. He is a Diplomate of the American Board of Foot and Ankle Surgery, Fellow of the American Society of Podiatric Surgeons, and is recognized as a “Master” by the American Professional Wound Care Association. He is a Fellow of the American Academy of Podiatric Practice Management and an Expert Panelist on Codingline. Dr. Lehrman is a Certified Professional Coder and in his role as a Consultant to the APMA Health Policy and Practice Department, he serves as an Advisor to the APMA Coding Committee and the APMA MACRA Task Force. Dr. Lehrman sits on the Board of Directors of both the American Professional Wound Care Association and the American Society of Podiatric Surgeons. He is an adjunct clinical professor at Temple University School of Podiatric Medicine. Dr. Lehrman is also on the editorial advisory board of the journal Wounds and is a consulting editor for Podiatry Management magazine.

Sponsored by:

By registering for this program, you consent to share your registration information with the program's sponsor.

Back to Top